Pedro M. Garcia-Barrantes

Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design.

Brian A. Chauder, E. Olejniczak, S. Fesik, 2013, Journal of medicinal chemistry.

Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators

Anna L. Blobaum, J. Cheer, C. Lindsley, 2018, Molecular Psychiatry.

Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia.

A. Megens, X. Langlois, J. Bartolomé-Nebreda, 2015, ACS medicinal chemistry letters.